Cargando…

Atrial fibrillation in patients with cardiac amyloidosis and heart failure: a desperate cause?

Detalles Bibliográficos
Autores principales:	Sellal, Jean-Marc, de Chillou, Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10098253/ https://www.ncbi.nlm.nih.gov/pubmed/37065604 http://dx.doi.org/10.1093/ehjopen/oead027

Ejemplares similares

New Perspective in Atrial Fibrillation
por: Sagnard, Audrey, et al.
Publicado: (2020)

Cardiac Remodeling and Diastolic Dysfunction in Paroxysmal Atrial Fibrillation
por: Noirclerc, Nathalie, et al.
Publicado: (2021)

Impact of Midregional N‐Terminal Pro–Atrial Natriuretic Peptide and Soluble Suppression of Tumorigenicity 2 Levels on Heart Rhythm in Patients Treated With Catheter Ablation for Atrial Fibrillation: The Biorhythm Study
por: Badoz, Marc, et al.
Publicado: (2021)

Catheter Ablation for Atrial Fibrillation in Patients with Heart Failure
por: Scanavacca, Mauricio, et al.
Publicado: (2018)

Editorial Genomics of Atrial Fibrillation and Heart Failure
por: Xiao, Junjie
Publicado: (2015)

Interaction Between Heart Failure and Atrial Fibrillation
por: Kim, Yun Gi
Publicado: (2022)

Transthyretin cardiac amyloidosis: an under-diagnosed cause of heart failure
por: Molina O, Gabriela, et al.
Publicado: (2014)

How to treat atrial fibrillation in patients with cardiac amyloidosis
por: Nomoto, Yu, et al.
Publicado: (2023)

Desperate times call for desperate measures
por: Şahin Duyar, Sezgi, et al.
Publicado: (2022)

Efficacy and Safety of Second and Third-Generation Laser Balloon for Paroxysmal Atrial Fibrillation Ablation Compared to Radiofrequency Ablation: A Matched-Cohort
por: Guenancia, Charles, et al.
Publicado: (2021)

Is Atrial Fibrillation Ablation Really Beneficial in Patients with Heart Failure?
por: Kim, Jin-Bae, et al.
Publicado: (2021)

Heart failure with preserved ejection fraction, atrial fibrillation, and the role of senile amyloidosis
por: van den Berg, Maarten P, et al.
Publicado: (2019)

Atrial Natriuretic Peptides as a Bridge between Atrial Fibrillation, Heart Failure, and Amyloidosis of the Atria
por: Rahbar Kouibaran, Farzad, et al.
Publicado: (2023)

Is There an Association between Epicardial Adipose Tissue and Outcomes after Paroxysmal Atrial Fibrillation Catheter Ablation?
por: Hammache, Néfissa, et al.
Publicado: (2021)

Cardiac amyloidosis—an underdiagnosed cause of heart failure in the elderly
por: Nazir, Tahir, et al.
Publicado: (2020)

Atrial fibrillation and heart failure temporality: does it matter?
por: Van Deutekom, Colinda, et al.
Publicado: (2022)

Running after Activated Clotting Time Values in Patients Receiving Direct Oral Anticoagulants: A Potentially Dangerous Race. Results from a Prospective Study in Atrial Fibrillation Catheter Ablation Procedures
por: Benali, Karim, et al.
Publicado: (2021)

Do ECMO First Even in the Desperate Situation
por: Heo, Jung Ho
Publicado: (2021)

Left cardiac sympathetic denervation for the treatment of inherited arrhythmia syndromes: salvation for the desperate?
por: Voskuil, M., et al.
Publicado: (2014)

Risk and Outcome after Ablation of Isthmus-Dependent Atrial Flutter in Elderly Patients
por: Brembilla-Perrot, Béatrice, et al.
Publicado: (2015)

COVID-19: desperate times call for desperate measures
por: von Düring, Stephan, et al.
Publicado: (2020)

Atrial Fibrillation and Heart Failure
por: Bergau, Leonard, et al.
Publicado: (2022)

Cardiac resynchronization therapy in heart failure patients with atrial fibrillation
por: Gasparini, Maurizio, et al.
Publicado: (2009)

Desperate games
por: Boulle, Pierre, 1912-1994
Publicado: (1973)

Morpho-functional changes of cardiac telocytes in isolated atrial amyloidosis in patients with atrial fibrillation
por: Sukhacheva, Tatyana V., et al.
Publicado: (2021)

Safety of Catheter Ablation Therapy for Atrial Fibrillation in Cardiac Amyloidosis
por: Alhassan, Hassan A., et al.
Publicado: (2023)

Desperately seeking Supersymmetry
por: De Roeck, Albert
Publicado: (2016)

Adverse outcomes of atrial fibrillation ablation in heart failure patients with and without cardiac amyloidosis: a Nationwide Readmissions Database analysis (2015–2019)
por: Ullah, Waqas, et al.
Publicado: (2023)

Annotations: Desperate Diseases, Desperate Remedies—Impossible!—A Sheffield "Scare"
Publicado: (1889)

Commentary: Angiotensin II for vasoplegia: A desperate measure for desperate times
por: Balsam, Leora B.
Publicado: (2020)

Editorial to “effectiveness of catheter ablation of atrial fibrillation according to heart failure etiology”
por: Bazoukis, George, et al.
Publicado: (2019)

Cardiac Amyloidosis Detected on Imaging of Patients with Heart Failure
por: Roginić, Siniša, et al.
Publicado: (2020)

Desperately looking for the right target in osteoarthritis: the anti-IL-1 strategy
por: Chevalier, Xavier, et al.
Publicado: (2011)

Atrial Fibrillation in the Elderly: The Role of Sub-Clinical Isolated Cardiac Amyloidosis
por: Krishnappa, Darshan, et al.
Publicado: (2019)

Desperately seeking synapses
por: Van Epps, Heather L.
Publicado: (2006)

Suspecting Cardiac Amyloidosis in Congestive Heart Failure
por: Alatassi, Emad U, et al.
Publicado: (2020)

Letter to the Editor in response to “COVID-19: desperate times call for desperate measures”
por: Chase, J. Geoffrey, et al.
Publicado: (2020)

DESPERATE TIMES CALL FOR DESPERATE MEASURES: GOVERNMENT SPENDING MULTIPLIERS IN HARD TIMES
por: Lee, Sokbae, et al.
Publicado: (2020)

Desperate Times, Desperate Measures: The Case for RRx-001 in the Treatment of COVID-19
por: Oronsky, Bryan., et al.
Publicado: (2020)

Cardiac amyloidosis as a rare cause of heart failure: A case report
por: Gao, Ming, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_mo6hk8dpeqrcfb1ffd3t32n1tp